Browsing publications by Professor Quentin Anstee

Newcastle AuthorsTitleYearFull text
Dr Stuart McPherson
Dr Nina Wilkinson
Dr Dina Tiniakos
Dr Jennifer Wilkinson
Professor Alastair Burt
et al.
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis2017
Professor Quentin Anstee
Dr Rebecca Darlay
Professor Heather Cordell
Professor Ann Daly
Professor Chris Day
et al.
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans2017
Professor Quentin Anstee
A fatty liver leads to a broken heart?2016
Dr Stuart McPherson
Dr Timothy Hardy
Dr Dina Tiniakos
Professor Alastair Burt
Professor Chris Day
et al.
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis2016
Professor Quentin Anstee
Professor Arun Sanyal
ALT as a non-invasive biomarker of histological response to pharmacotherapy in NASH patients: insights from the elafibranor GOLDEN505 trial2016
Dr Stuart McPherson
Professor Quentin Anstee
Changing Epidemiology of Chronic Liver Disease Among Ethnic Groups in the United States2016
Professor Quentin Anstee
Professor Chris Day
Professor Alastair Burt
Dr John Brain
Dr Yvonne Bury
et al.
Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference2016
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Chris Day
Diagnostic performance of FibroTest, SteatoTest, and ActiTest in patients with NAFLD using the SAF-score as histological reference2016
Professor Quentin Anstee
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening2016
Dr Dave Houghton
Dr Sophie Cassidy
Dr Kate Hallsworth
Dr Kieren Hollingsworth
Professor Roy Taylor
et al.
Exercise reduces liver fat and improves body composition but not insulin sensitivity or inflammatory markers in non-alcoholic steatohepatitis2016
1234567891011121314